Table 2a.

a. Association between thrombosis and the presence of IgG anti-cardiolipin (CL), IgG anti-β₂-glycoprotein I (β₂-GPI) and IgG anti-mitochondrial M5 type antibodies (AMA M5) individually evaluated or between the joint presence of IgG AMA M5 plus IgG aCL or IgG AMA M5 plus IgG anti-β₂-GPI. b. Association between thrombocytopenia and the presence of IgG anti-CL, IgG anti-β₂-GPI and IgG AMA M5 individually evaluated or between the joint presence of IgG AMA M5 plus IgG aCL or IgG AMA M5 plus IgG anti-β₂-GPI. c. Association between recurrent fetal loss and the presence of IgG anti-CL, IgG anti-β₂-GPI and IgG AMA M5 individually evaluated or between the joint presence of IgG AMA M5 plus IgG aCL or IgG AMA M5 plus IgG anti-β₂-GPI